# Intrinsic Stiffness of Aortic Vascular Smooth Muscle Cell in the Development of Hypertension

> **NIH NIH R01** · GEORGIA STATE UNIVERSITY · 2021 · $141,505

## Abstract

PROJECT SUMMARY of the Supplement
 The parent project was proposed to investigate the role of the activation of SRF in aortic stiffening,
however, the mechanisms underlying the increase of SRF in hypertensive VSMCs remains unknown. The work
performed on the parent grant directly led to the identification of interleukin 36 receptor (IL-36R), an
inflammatory regulator, which was dramatically increased in the hypertensive aortic tissue and VSMCs, and
established a potential link of the IL-36R with SRF activation in hypertensive VSMCs. These new findings built
the foundation of the present supplemental application. One of the goals of this supplement is to expand the
research of the parent grant to explore the potential role of IL-36R in the development of aortic stiffening in
hypertension and its association with SRF-mediated signaling. Another goal of this supplement is to support
the candidate’s investigation in this new research area extended from the parent grant, and help her to become
an R01-funded principal investigator in 1-2 years. Based on our preliminary data, we hypothesize that the
upregulation of IL-36R contributes to aortic stiffness in hypertension by increasing VSMC stiffness through
SRF-mediated signaling. We plan to test this hypothesis by pursuing the following specific aims: Aim 1:
Determine the role of IL-36R in VSMC stiffness and its regulation on SRF–mediated signaling in vitro.
We will use a gain- and loss-of-function strategy to identify IL-36R-dependent effects at the cell level. We will
test whether overexpressing IL-36R in WKY VSMCs increases the VSMC stiffness, and whether knocking-
down IL-36R results in a reversal of the enhanced stiffness of SHR VSMCs. In addition, we will use IL-36R
agonists and antagonists to determine whether the effect of IL-36R requires activation by an IL-36 cytokine.
The VSMCs stiffness will be measured by AFM and 3D constituted tissue models as we proposed in the parent
grant. We will also determine whether overexpressing or knocking down IL-36R in VSMCs induces a parallel
alteration on the SRF-mediated signaling by testing the key genes and proteins as demonstrated in the parent
grant. Specific Aim 2: Determine the role of IL-36R in the development of aortic stiffening and
hypertension in vivo. To accomplish this, we will determine whether IL-36R is necessary for the regulation of
aortic stiffness by using a VSMC-specific IL-36R KO mouse model. We will test whether the deletion of IL-36R
affects the aortic stiffening and blood pressure induced by Angiotensin II in these mice. The aortic stiffness will
be measured both in vivo and ex vivo as we described in the parent proposal. The VSMC stiffness and
involved signaling will be determined in the isolated TA VSMCs from these mice as proposed in the Aim1. We
expect that this supplement will discover novel mechanisms that may link the IL-36R with SRF-mediated
intracellular signaling which will lead to a better understanding in the pathogenesis of...

## Key facts

- **NIH application ID:** 10275468
- **Project number:** 3R01HL115195-09S1
- **Recipient organization:** GEORGIA STATE UNIVERSITY
- **Principal Investigator:** Hongyu Qiu
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $141,505
- **Award type:** 3
- **Project period:** 2019-06-12 → 2023-01-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10275468

## Citation

> US National Institutes of Health, RePORTER application 10275468, Intrinsic Stiffness of Aortic Vascular Smooth Muscle Cell in the Development of Hypertension (3R01HL115195-09S1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10275468. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*